Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Healthcare Triangle has signed a non-binding letter of intent to acquire Spain-based Teyame.AI, aiming to create an integrated AI-driven global patient engagement platform projected to add $34 million in revenue for fiscal year 2025.
A new study by Bain & Company and KLAS Research shows U.S. healthcare providers and payers are prioritizing AI investments that deliver measurable financial returns, with revenue cycle management and clinical workflows emerging as top areas of focus.
Carta Healthcare has been named to CB Insights' 2025 Digital Health 50 list, recognized in the Clinical Workflow Automation category for its AI-powered clinical data abstraction solutions.
The global IoT in healthcare market is projected to reach $594.5 billion by 2035, driven by AI-powered analytics, wearable devices, and smart hospital investments, according to Vantage Market Research.
Simple Life, an AI-powered health coaching app, has raised $35 million in a Series B round led by Hartbeat Ventures and Liquidity to expand its personalized weight management technology.
UST has entered multi-year agreements worth over $2 billion with three major healthcare companies, focusing on AI-driven personalization, automation, and data intelligence to enhance patient experiences and operational efficiency.
Expert.ai announced new AI-powered solutions at BioTechX Europe 2025 to improve research, clinical trial design, and regulatory processes across the pharmaceutical and life sciences industries.
Levitate has achieved HIPAA readiness and expanded its relationship-first marketing platform to healthcare providers, including dental and chiropractic practices, enabling compliant patient communication and engagement tools.
PureHealth has finalized the acquisition of a 60% stake in Hellenic Healthcare Group for €800 million, expanding its international footprint into Greece and Cyprus.
Biocare Medical and Hamamatsu have announced a strategic collaboration to deliver an integrated spatial biology solution combining staining and imaging systems for research institutions and biopharma companies.
Caris Life Sciences reported third-quarter 2025 revenue of $216.8 million, up 113% year-over-year, and raised its full-year revenue guidance to $720–$730 million.
Scott Roberts and John Czekanski have launched MOMENTUS Biopharma Consulting, a strategic firm leveraging AI and technology to support biopharma clients across the therapeutic lifecycle, according to a press release.
At the 27th Annual SoCalBio Conference, experts from RKS Design, NeuraSignal, Avenda Health, DigitalDx Ventures, and Johnson & Johnson discussed how AI can be effectively integrated into clinical workflows and reimbursement systems.
Philadelphia-based biotech LIV Process has introduced a patented technology that makes the pathogen Clostridioides difficile visible on surfaces, allowing hospitals to detect contamination invisible to the naked eye.
SYNERGEN Health has announced a strategic collaboration with Lighthouse Lab Services to deliver AI-enabled revenue cycle management solutions tailored for laboratories, aiming to improve collections, reduce denials, and enhance financial sustainability.
Cohere Health has partnered with Microsoft to integrate its AI-driven prior authorization technology into Dragon Copilot, enabling clinicians to automate care requests in real time during patient visits.
Pretty Good AI will showcase its clinic intelligence platform and AI voice technology at Thrive Summit 2025 in Nashville. The company will also host a webinar for athenaOne practices ahead of the event.
QDcme has introduced adaptive AI learning for oncologists and curated microlearning tools for primary care clinicians, marking its first anniversary and expanding its medical education offerings.
WIRobotics has received the CES 2026 Innovation Award in the Digital Health category for its WIM KIDS wearable walking assistance robot designed for children aged 4 to 15.
Royal Philips reported third-quarter earnings above expectations, supported by new AI-powered medical tools and actions to offset tariff impacts. The company recorded €531 million in adjusted EBITA and a 3% increase in sales, led by strong North American performance.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
